Although we detected ALK phosphorylation by IHC in almost half of the MCC tumors studied, it is still infeasible to make conclusions about the potential in vivo efficacy of ALK inhibitors in MCC tumors. This evidence concerns the gene ALK and Merkel cell skin cancer.